Table 3.
Comparison of tumor data for gastric cancer patients with and without autoimmune gastritis (AIG).
| Parameter | AIG | No AIG | p-value | OR (95% CI) |
|---|---|---|---|---|
| N | 28 | 56 | – | – |
| Early gastric cancer (%) | 18 (64) | 11 (20) | 0.00005 | 7.4 (2.7–20.3) |
| UICC: I–II (%) | 22 (79) | 22 (39) | 0.0007 | 5.7 (2.0–16.2) |
| UICC: I–III (%) | 26 (93) | 38 (68) | 0.011 | 6.2 (1.3–28.8) |
| Grading: G1–G2 (%) | 13 (46) | 21 (38) | 0.432 | 1.4 (0.6–3.6) |
| Treatment with curative intention (%) | 23 (82) | 34 (61) | 0.047 | 3.0 (1.0–9.0) |
UICC: Union for International Cancer Control; CI: confidence interval; OR: odds ratio.
p-values ≤ 0.05 (bold) are statistically significant (X2 test).